ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 2 analysts with an average price target of $15.5. This is a potential upside of $6.27 (67.93%) from yesterday's end of day stock price of $9.23.

Atara Biotherapeutics's activity chart (see below) currently has 73 price targets and 97 ratings on display. The stock rating distribution of ATRA is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.21% with an average time for these price targets to be met of 203.05 days.

Highest price target for ATRA is $18, Lowest price target is $13, average price target is $15.5.

Most recent stock forecast was given by from CANACCORD on 08-May-2026. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-May-2026

$13

$2.49 (23.69%)

$6

5 months 1 days ago
(08-May-2026)

5/7 (71.43%)

$4.66 (55.88%)

542

Buy Since 18-Aug-2025

$18

$7.49 (71.27%)

$16

10 months 18 days ago
(21-Nov-2025)

4/6 (66.67%)

$4.32 (31.58%)

167

Hold Since 22-May-2024

1 years 8 months 11 days ago
(28-Jan-2025)

2/6 (33.33%)

$437.5 (129.63%)

149

Hold Since 02-Nov-2023

$5

$-5.51 (-52.43%)

$10

1 years 8 months 18 days ago
(21-Jan-2025)

3/5 (60%)

$-1.05 (-17.36%)

310

Buy Since 30-May-2019

$7

$-2.48 (-26.16%)

$25

1 years 8 months 18 days ago
(21-Jan-2025)

1/6 (16.67%)

$0.95 (15.70%)

3

Show more analysts

Please expand the browser size to see the chart

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 203 days for the stock forecasts to be reached, with an average price target met ratio of 57.21%.

Which analyst most recently updated their price target on ATRA (Atara Biotherapeutics)?

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

has 0 price targets and 0 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with the highest potential upside of $615.52

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Benjamin Burnett with the lowest potential downside of -$5.51
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?